Terconazole

Name: Terconazole
Brand: SIAL

VETRANAL^®, analytical standard

동의어(들):

(+-)-1-{4-[cis-2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-ylmethoxy]phenyl}-4-isopropylpiperazine, Triaconazole

조직 및 계약 가격을 보려면 로그인를 클릭합니다.

크기 선택

제품정보 (DICE 배송 시 비용 별도)

실험식(Hill 표기법):

C₂₆H₃₁Cl₂N₅O₃

CAS 번호:

67915-31-5

Molecular Weight:

532.46

MDL number:

MFCD05662369

UNSPSC Code:

41116107

EC Number:

267-751-6

NACRES:

NA.24

주요 문서

모든 문서 보기

기술 서비스

도움이 필요하신가요? 저희 숙련된 과학자 팀이 도와드리겠습니다.

도움 문의

기술 서비스

도움이 필요하신가요? 저희 숙련된 과학자 팀이 도와드리겠습니다.

도움 문의

grade

analytical standard

SMILES string

Clc1c(ccc(c1)Cl)[C@@]3(O[C@H](CO3)COc4ccc(cc4)N5CCN(CC5)C(C)C)C[n]2ncnc2

InChI key

BLSQLHNBWJLIBQ-OZXSUGGESA-N

InChI

1S/C26H31Cl2N5O3/c1-19(2)31-9-11-32(12-10-31)21-4-6-22(7-5-21)34-14-23-15-35-26(36-23,16-33-18-29-17-30-33)24-8-3-20(27)13-25(24)28/h3-8,13,17-19,23H,9-12,14-16H2,1-2H3/t23-,26-/m0/s1

product line

VETRANAL^®

technique(s)

HPLC: suitable, gas chromatography (GC): suitable

application(s)

forensics and toxicology
veterinary

format

neat

Quality Level

100

유사한 제품을 찾으십니까? 방문 제품 비교 안내

Application

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

Legal Information

VETRANAL is a registered trademark of Merck KGaA, Darmstadt, Germany

pictograms

GHS07

signalword

Warning

hcodes

H315,H319,H335,H413

pcodes

P261 - P305 + P351 + P338

Hazard Classifications

Aquatic Chronic 4 - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

저장 등급

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

가장 최신 버전 중 하나를 선택하세요:

시험 성적서(COA)

Lot/Batch Number

적합한 버전을 찾을 수 없으신가요?

특정 버전이 필요한 경우 로트 번호나 배치 번호로 특정 인증서를 찾을 수 있습니다.

COA 검색

이 제품을 이미 가지고 계십니까?

문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

문서 라이브러리 방문

The in vitro activity of terconazole against yeasts: its topical long-acting therapeutic efficacy in experimental vaginal candidiasis in rats.

J Van Cutsem

American journal of obstetrics and gynecology, 165(4 Pt 2), 1200-1206 (1991-10-01)

The activity of the broad-spectrum triazole antifungal terconazole was evaluated in vitro by the serial decimal dilution technique in broth media. The best correlation between in vitro and in vivo activity was found in brain-heart infusion broth and Eagle's minimum

Comparison of 0.8% and 1.6% terconazole cream in severe vulvovaginal candidiasis.

C Schmitt et al.

Obstetrics and gynecology, 76(3 Pt 1), 414-416 (1990-09-01)

Terconazole is the first topical triazole antifungal agent. The results of several European clinical trials have shown both terconazole cream and suppositories to be effective and safe in the treatment of vulvovaginal candidiasis. We conducted a comparative placebo-controlled, double-blind study

In vitro susceptibility of clinical yeast isolates to fluconazole and terconazole.

C R Cooper et al.

American journal of obstetrics and gynecology, 175(6), 1626-1631 (1996-12-01)

Fifty clinical yeast isolates, representing equally Candida albicans, Candida krusei, Candida parapsilosis, Candida tropicalis, and Torulopsis glabrata, were tested in vitro for their susceptibility to terconazole and fluconazole. The minimal inhibitory concentrations of terconazole and fluconazole were determined by use

About the role of enantioselective selector-selectand interactions and the mobilities of diastereomeric associates in enantiomer separations using CE.

Ketevan Lomsadze et al.

Electrophoresis, 30(16), 2803-2811 (2009-08-04)

It is generally accepted that the selective binding of enantiomers of the chiral analyte to a chiral selector is necessary for enantioseparations in CE, whereas the role of mobility differences between the temporary diastereomeric associates formed between the enantiomers and

Fever and leukocytosis related to terconazole vaginal suppository.

S S Hyder et al.

Southern medical journal, 87(7), 762-763 (1994-07-01)

We describe a 22-year-old woman who developed fever, shaking chills, and leukocytosis after insertion of a terconazole (80 mg) vaginal suppository for mild vaginal candidiasis. The patient became afebrile and asymptomatic 24 hours after hospital admission without antibiotic therapy. More

모든 관련된 서류 보기

자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..

고객지원팀으로 연락바랍니다.

Terconazole

VETRANAL^®, analytical standard

크기 선택

제품정보 (DICE 배송 시 비용 별도)

주요 문서

속성

grade

SMILES string

InChI key

InChI

product line

technique(s)

application(s)

format

Quality Level

관련 카테고리

설명

Application

Legal Information

안전성 정보

pictograms

signalword

hcodes

pcodes

Hazard Classifications

target_organs

저장 등급

wgk

flash_point_f

flash_point_c

문서

시험 성적서(COA)

이 제품을 이미 가지고 계십니까?

관련 참고 논문

기술 서비스

Terconazole

VETRANAL®, analytical standard

크기 선택

제품정보 (DICE 배송 시 비용 별도)

주요 문서

속성

grade

SMILES string

InChI key

InChI

product line

technique(s)

application(s)

format

Quality Level

관련 카테고리

설명

Application

Legal Information

안전성 정보

pictograms

signalword

hcodes

pcodes

Hazard Classifications

target_organs

저장 등급

wgk

flash_point_f

flash_point_c

문서

시험 성적서(COA)

이 제품을 이미 가지고 계십니까?

관련 참고 논문

기술 서비스

VETRANAL^®, analytical standard